General Information of the Compound
Compound ID |
CP0380786
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
2-{2-[2-[2-Acetylamino-3-(3H-imidazol-4-yl)-propionylamino]-3-(1H-indol-3-yl)-propionylamino]-propionylamino}-N-{[2-(3H-imidazol-4-yl)-1-(3-methyl-1-propyl-butylcarbamoyl)-ethylcarbamoyl]-methyl}-3-methyl-butyramide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C43H62N12O7
|
||||||||||||||||||
Molecular Weight |
859.046
|
||||||||||||||||||
Canonical SMILES |
CCC[C@@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(C)=O)C(C)C
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C43H62N12O7/c1-8-11-29(14-24(2)3)52-41(60)36(17-31-20-45-23-49-31)53-37(57)21-47-43(62)38(25(4)5)55-39(58)26(6)50-40(59)34(15-28-18-46-33-13-10-9-12-32(28)33)54-42(61)35(51-27(7)56)16-30-19-44-22-48-30/h9-10,12-13,18-20,22-26,29,34-36,38,46H,8,11,14-17,21H2,1-7H3,(H,44,48)(H,45,49)(H,47,62)(H,50,59)(H,51,56)(H,52,60)(H,53,57)(H,54,61)(H,55,58)/t26-,29-,34-,35-,36-,38-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
SNIFLSAJCDXIOR-XMNJRNTESA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound